Monte Carlo study of TG-43 dosimetry parameters of GammaMed Plus high dose rate 192Ir brachytherapy source using TOPAS

被引:3
|
作者
Wu, Jianan [1 ,2 ,3 ]
Xie, Yaoqin [1 ]
Ding, Zhen [2 ,3 ]
Li, Feipeng [4 ]
Wang, Luhua [2 ,3 ,5 ]
机构
[1] Chinese Acad Sci, Shenzhen Inst Adv Technol, Inst Biomed & Hlth Engn, Shenzhen 518055, Peoples R China
[2] Chinese Acad Med Sci & Peking Union Med Coll, Dept Radiat Oncol, Natl Canc Ctr, Canc Hosp,Natl Clin Res Ctr Canc, Shenzhen 518116, Peoples R China
[3] Chinese Acad Med Sci & Peking Union Med Coll, Shenzhen Hosp, Shenzhen 518116, Peoples R China
[4] Shenzhen Univ, Coll Math & Stat, Shenzhen Key Lab Adv Machine Learning & Applicat, Shenzhen 518060, Peoples R China
[5] Chinese Acad Med Sci & Peking Union Med Coll, Dept Radiat Oncol, Natl Canc Ctr, Canc Hosp,Natl Clin Res Ctr Canc, Beijing 100021, Peoples R China
来源
关键词
2004; UPDATE; AAPM; RECOMMENDATIONS; SIMULATIONS; SUPPLEMENT; SPECTRA; KERMA;
D O I
10.1002/acm2.13252
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Purpose To develop a simulation model for GammaMed Plus high dose rate Ir-192 brachytherapy source in TOPAS Monte Carlo software and validate it by calculating the TG-43 dosimetry parameters and comparing them with published data. Methods We built a model for GammaMed Plus high dose rate brachytherapy source in TOPAS. The TG-43 dosimetry parameters including air-kerma strength S-K, dose-rate constant ?, radial dose function g(L)(r), and 2D anisotropy function F(r,theta) were calculated using Monte Carlo simulation with Geant4 physics models and NNDC Ir-192 spectrum. Calculations using an old Ir-192 spectrum were also carried out to evaluate the impact of incident spectrum and cross sections. The results were compared with published data. Results For calculations using the NNDC spectrum, the air-kerma strength per unit source activity S-K/A and ? were 1.0139 x 10(-7) U/Bq and 1.1101 cGy.h(-1).U-1, which were 3.56% higher and 0.62% lower than the reference values, respectively. The g(L)(r) agreed with reference values within 1% for radial distances from 2 mm to 20 cm. For radial distances of 1, 3, 5, and 10 cm, the agreements between F(r,theta) from this work and the reference data were within 1.5% for 15 degrees theta < 165 degrees, and within 4% for all theta values. The discrepancies were attributed to the updated source spectrum and cross sections. They caused deviations of the S-K/A of 2.90% and 0.64%, respectively. As for g(L)(r), they caused average deviations of -0.22% and 0.48%, respectively. Their impact on F(r,theta) was not quantified for the relatively high statistical uncertainties, but basically they did not result in significant discrepancies. Conclusion A model for GammaMed Plus high dose rate Ir-192 brachytherapy source was developed in TOPAS and validated following TG-43 protocols, which can be used for future studies. The impact of updated incident spectrum and cross sections on the dosimetry parameters was quantified.
引用
收藏
页码:146 / 153
页数:8
相关论文
共 50 条
  • [1] Investigation of TG-43 Dosimetric Parameters for 192Ir Brachytherapy Source Using GATE Monte Carlo Code
    Joya, Musa
    Nedaie, Hassan Ali
    Geraily, Ghazale
    Rezaei, Hadi
    Bromand, Awaz
    Ghorbani, Mahdi
    Sheikhzadeh, Peyman
    [J]. JOURNAL OF MEDICAL PHYSICS, 2023, 48 (03) : 268 - 273
  • [2] Monte Carlo dosimetry of the IRAsource high dose rate 192Ir brachytherapy source
    Sarabiasl, Akbar
    Ayoobian, Navid
    Jabbari, Iraj
    Poorbaygi, Hossein
    Javanshir, Mohammad Reza
    [J]. Australasian Physical and Engineering Sciences in Medicine, 2016, 39 (02): : 413 - 422
  • [3] Monte Carlo dosimetry of a new 192Ir high dose rate brachytherapy source
    Angelopoulos, A
    Baras, P
    Sakelliou, L
    Karaiskos, P
    Sandilos, P
    [J]. MEDICAL PHYSICS, 2000, 27 (11) : 2521 - 2527
  • [4] Erratum to: Monte Carlo dosimetry of the IRAsource high dose rate 192Ir brachytherapy source
    Akbar Sarabiasl
    Navid Ayoobian
    Hossein Poorbaygi
    Iraj Jabbari
    Mohammad Reza Javanshir
    [J]. Australasian Physical & Engineering Sciences in Medicine, 2016, 39 : 591 - 591
  • [5] Monte Carlo and TLD dosimetry of an 192Ir high dose-rate brachytherapy source
    Karaiskos, P
    Angelopoulos, A
    Sakelliou, L
    Sandilos, P
    Antypas, C
    Vlachos, L
    Koutsouveli, E
    [J]. MEDICAL PHYSICS, 1998, 25 (10) : 1975 - 1984
  • [6] Monte Carlo dosimetry of a new 192Ir pulsed dose rate brachytherapy source
    Karaiskos, P
    Angelopoulos, A
    Pantelis, E
    Papagiannis, P
    Sakelliou, L
    Kouwenhoven, E
    Baltas, D
    [J]. MEDICAL PHYSICS, 2003, 30 (01) : 9 - 16
  • [7] Monte Carlo dosimetry of the Buchler high dose rate 192Ir source
    Ballester, F
    Pérez-Calatayud, J
    Puchades, V
    Lluch, JL
    Serrano-Andrés, MA
    Limami, Y
    Lliso, F
    Casal, E
    [J]. PHYSICS IN MEDICINE AND BIOLOGY, 2001, 46 (03): : N79 - N90
  • [8] Monte Carlo dosimetry of the VariSource high dose rate 192Ir source
    Wang, RQ
    Sloboda, RS
    [J]. MEDICAL PHYSICS, 1998, 25 (04) : 415 - 423
  • [9] Comparative dosimetry of GammaMed Plus high-dose rate Ir-192 brachytherapy source
    Patel, N. P.
    Majumdar, B.
    Vijayan, V.
    [J]. JOURNAL OF MEDICAL PHYSICS, 2010, 35 (03) : 137 - 143
  • [10] Dosimetric and radiobiological comparison of TG-43 and Monte Carlo calculations in 192Ir breast brachytherapy applications
    Peppa, V.
    Pappas, E. P.
    Karaiskos, P.
    Major, T.
    Polgar, C.
    Papagiannis, P.
    [J]. PHYSICA MEDICA-EUROPEAN JOURNAL OF MEDICAL PHYSICS, 2016, 32 (10): : 1245 - 1251